Replacing confusion with clarity: Global Cancer Care launches Mumbai ops to tackle detection delays
The initiative is focused on a problem that continues to plague cancer outcomes in India
The initiative is focused on a problem that continues to plague cancer outcomes in India
Tirzepatide is the first and only dual agonist glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
Subscribe To Our Newsletter & Stay Updated